New Equilibrium Biosciences
Boston, US · Founded 2019 · Delaware corporation
Founders & leadership
VB
Virginia BurgerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10.2M disclosed across 2 rounds · 2019–2021
▶$10MraisedApr 2022 · 3 investors · BiotechnologyRule 506(b)
▶$10MraisedApr 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Virginia BurgerExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$250KraisedJan 2020 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJan 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Virginia BurgerExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2020 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has New Equilibrium Biosciences raised?
- New Equilibrium Biosciences has disclosed $10.2M raised across 2 rounds.
- Where is New Equilibrium Biosciences headquartered?
- New Equilibrium Biosciences is headquartered in Boston, US.